<![CDATA[Biotek-snakken — Marts 2024]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/topic/401441/biotek-snakken-marts-2024RSS for NodeSat, 06 Jun 2026 07:33:09 GMTFri, 01 Mar 2024 03:36:05 GMT60<![CDATA[Reply to Biotek-snakken — Marts 2024 on Fri, 29 Mar 2024 12:29:41 GMT]]>Why Viking Therapeutics Stock Was Rocketing Higher This Week https://www.proinvestor.com/investornyt/1138232/why-viking-therapeutics-stock-was-rocketing-higher-this-week

]]>https://dev.proinvestor.com/forum/post/8067229https://dev.proinvestor.com/forum/post/8067229Fri, 29 Mar 2024 12:29:41 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Fri, 29 Mar 2024 12:28:55 GMT]]>Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals https://www.proinvestor.com/investornyt/1138230/better-buy-viking-therapeutics-vs-madrigal-pharmaceuticals

]]>https://dev.proinvestor.com/forum/post/8067232https://dev.proinvestor.com/forum/post/8067232Fri, 29 Mar 2024 12:28:55 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Fri, 29 Mar 2024 05:54:15 GMT]]>Applied Therapeutics Says FDA Extends Review Period Of NDA For Govorestat https://www.proinvestor.com/investornyt/1138140/applied-therapeutics-says-fda-extends-review-period-of-nda-for-govorestat

]]>https://dev.proinvestor.com/forum/post/8067227https://dev.proinvestor.com/forum/post/8067227Fri, 29 Mar 2024 05:54:15 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Fri, 29 Mar 2024 05:16:47 GMT]]>NeuroBo Pharma offentliggør regnskabsresultat 2023 og forventninger til 2024. Lovende data mht. DA-1726 (fedme) og har likvider t.o.m. 2024. Financieringsbehov på sigt. https://www.neurobopharma.com/news-releases/news-release-details/neurobo-pharmaceuticals-reports-year-end-2023-financial-results

]]>https://dev.proinvestor.com/forum/post/8067230https://dev.proinvestor.com/forum/post/8067230Fri, 29 Mar 2024 05:16:47 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Fri, 29 Mar 2024 05:08:33 GMT]]>Arcadia Biosciences (RKDA) Reports Q4 Loss, Misses Revenue Estimates https://www.proinvestor.com/investornyt/1138130/arcadia-biosciences-rkda-reports-q4-loss-misses-revenue-estimates

]]>https://dev.proinvestor.com/forum/post/8067224https://dev.proinvestor.com/forum/post/8067224Fri, 29 Mar 2024 05:08:33 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Fri, 29 Mar 2024 04:58:22 GMT]]>Akebia gets FDA approval of renal anaemia therapy Vafseo https://firstwordpharma.com/story/5841297?from=article

]]>https://dev.proinvestor.com/forum/post/8067222https://dev.proinvestor.com/forum/post/8067222Fri, 29 Mar 2024 04:58:22 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Fri, 29 Mar 2024 04:56:14 GMT]]>Aeovian moves seizure candidate into the clinic, raises $50M
AV078 is an mTORC1 inhibitor in development for tuberous sclerosis complex (TSC) epilepsy. https://firstwordpharma.com/story/5841451?from=article

]]>https://dev.proinvestor.com/forum/post/8067225https://dev.proinvestor.com/forum/post/8067225Fri, 29 Mar 2024 04:56:14 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Fri, 29 Mar 2024 04:55:31 GMT]]>Aldeyra preps rebound bid for dry-eye hopeful reproxalap https://firstwordpharma.com/story/5841474?from=article

]]>https://dev.proinvestor.com/forum/post/8067231https://dev.proinvestor.com/forum/post/8067231Fri, 29 Mar 2024 04:55:31 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Wed, 27 Mar 2024 13:52:32 GMT]]>Zai Lab Partner Novocure's Metis Phase 3 Trial Meets Primary Endpoint In Brain Metastases https://www.proinvestor.com/investornyt/1137338/zai-lab-partner-novocures-metis-phase-3-trial-meets-primary-endpoint-in-brain-metastases

]]>https://dev.proinvestor.com/forum/post/8067228https://dev.proinvestor.com/forum/post/8067228Wed, 27 Mar 2024 13:52:32 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Wed, 27 Mar 2024 06:19:35 GMT]]>Lundbeck harvfået godkendt langtidsvirkende medicin mod skizofreni. Er det noget der batter noget?

]]>https://dev.proinvestor.com/forum/post/8067221https://dev.proinvestor.com/forum/post/8067221Wed, 27 Mar 2024 06:19:35 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Tue, 26 Mar 2024 10:48:07 GMT]]>VKTX er pt oppe med 17% i premaket. Det bliver spændende at følge udviklingen i den i dag 🙂

]]>https://dev.proinvestor.com/forum/post/8067220https://dev.proinvestor.com/forum/post/8067220Tue, 26 Mar 2024 10:48:07 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Tue, 26 Mar 2024 10:42:42 GMT]]>Up to 3.3% Placebo-Adjusted Mean Weight Loss (5.3% from Baseline) Observed After 28 Days

]]>https://dev.proinvestor.com/forum/post/8067226https://dev.proinvestor.com/forum/post/8067226Tue, 26 Mar 2024 10:42:42 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Tue, 26 Mar 2024 10:40:24 GMT]]>Oral data på VK2735 er ude: https://ir.vikingtherapeutics.com/2024-03-26-Viking-Therapeutics-Announces-Results-from-Phase-1-Clinical-Trial-of-Oral-Tablet-Formulation-of-Dual-GLP-1-GIP-Receptor-Agonist-VK2735

]]>https://dev.proinvestor.com/forum/post/8067217https://dev.proinvestor.com/forum/post/8067217Tue, 26 Mar 2024 10:40:24 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Tue, 26 Mar 2024 09:31:23 GMT]]>Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics? https://www.proinvestor.com/investornyt/1136593/best-obesity-drug-stock-eli-lilly-novo-nordisk-or-viking-therapeutics

]]>https://dev.proinvestor.com/forum/post/8067216https://dev.proinvestor.com/forum/post/8067216Tue, 26 Mar 2024 09:31:23 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Tue, 26 Mar 2024 07:37:03 GMT]]>Mit håb er, at de ca. 2,5 mia usd og 1,5 mia usd som Pfizer får for deres aktier i Haleon og Cerevel skal bruges på et bud på viking 🙂

]]>https://dev.proinvestor.com/forum/post/8067223https://dev.proinvestor.com/forum/post/8067223Tue, 26 Mar 2024 07:37:03 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Tue, 26 Mar 2024 04:33:29 GMT]]>I fredags fristede VKTX RSI og MACD for meget, så snuppede en lille portion, som supplement til et kommende ZEAL-genkøb, forhåbentlig inden så længe.

]]>https://dev.proinvestor.com/forum/post/8067212https://dev.proinvestor.com/forum/post/8067212Tue, 26 Mar 2024 04:33:29 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Sun, 24 Mar 2024 13:14:27 GMT]]>Is Viking Therapeutics Stock a Millionaire Maker? https://www.proinvestor.com/investornyt/1135925/is-viking-therapeutics-stock-a-millionaire-maker

]]>https://dev.proinvestor.com/forum/post/8067213https://dev.proinvestor.com/forum/post/8067213Sun, 24 Mar 2024 13:14:27 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Sat, 23 Mar 2024 10:12:24 GMT]]>Where Will Viking Therapeutics Stock Be in 10 Years?

Viking Therapeutics (NASDAQ: VKTX) now ranks among the hottest biotech stocks on the market. The company's announcement in February of positive results from its phase 2 study of experimental weight loss drug VK2735 provided a huge catalys https://www.proinvestor.com/investornyt/1135788/where-will-viking-therapeutics-stock-be-in-10-years

]]>https://dev.proinvestor.com/forum/post/8067215https://dev.proinvestor.com/forum/post/8067215Sat, 23 Mar 2024 10:12:24 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Sat, 23 Mar 2024 03:59:16 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8067214https://dev.proinvestor.com/forum/post/8067214Sat, 23 Mar 2024 03:59:16 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Fri, 22 Mar 2024 05:08:01 GMT]]>OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://www.proinvestor.com/investornyt/1135280/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked

]]>https://dev.proinvestor.com/forum/post/8067211https://dev.proinvestor.com/forum/post/8067211Fri, 22 Mar 2024 05:08:01 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Thu, 21 Mar 2024 22:11:26 GMT]]>William Blair's Andy Hsieh - VK2735 kan ende op med at være en forbedret version af Tirzepatide.
https://www.biotechtv.com/post/andy-hsieh-march-21-2024
Snak om Viking starter 8:45 minutter inde i indslaget.

]]>https://dev.proinvestor.com/forum/post/8067218https://dev.proinvestor.com/forum/post/8067218Thu, 21 Mar 2024 22:11:26 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Thu, 21 Mar 2024 15:54:33 GMT]]>Kort video: Speedsnak om FED og fedmemedicin..Her tager Helge Larsen temperaturen på Novo Nordisk, Zealand Pharma og ikke mindst Gubra, som er blevet en vældig populær aktie inden for den seneste måned og især de sidste par dage. Han kommer også med nogle advarsler, der er gode at tage med sig generelt, når man investerer i biotek. https://www.proinvestor.com/boards/119446

]]>https://dev.proinvestor.com/forum/post/8067219https://dev.proinvestor.com/forum/post/8067219Thu, 21 Mar 2024 15:54:33 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Wed, 20 Mar 2024 12:36:46 GMT]]>Investeringspodcasten 214: Novo Nordisk split, GN Store Nord, NVIDIA, Demant, renter & Japan. https://www.proinvestor.com/boards/119435

]]>https://dev.proinvestor.com/forum/post/8067209https://dev.proinvestor.com/forum/post/8067209Wed, 20 Mar 2024 12:36:46 GMT<![CDATA[Reply to Biotek-snakken — Marts 2024 on Wed, 20 Mar 2024 08:58:30 GMT]]>Novo har også et program der går efter samme target. Så man kan nok forvente flere søger det space efter oral small molecue muligheder

]]>https://dev.proinvestor.com/forum/post/8067208https://dev.proinvestor.com/forum/post/8067208Wed, 20 Mar 2024 08:58:30 GMT